ALPHAVAX, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 16239
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 13154
 
  
 
C07K PEPTIDES 5131
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 396
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 293
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 247
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 198
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 1124

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2012/0128,714 Alphavirus Replicon Particles Expressing TRP2Apr 08, 10May 24, 12[A61K, A61P]
2009/0047,255 Alphavirus and Alphavirus Replicon Particle Formulations and MethodsNov 02, 07Feb 19, 09[A61K, C12N, A61P]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9597414 Use of microRNAs to control virus helper nucleic acidsFeb 05, 14Mar 21, 17[C07H, A61K, C12N, C07K]
9441247 TC-83-derived alphavirus vectors, particles and methodsJul 06, 15Sep 13, 16[A61K, C12N, C07K]
9416370 Alphavirus replicon particles matched to protein antigens as immunological adjuvantsOct 18, 10Aug 16, 16[A61K, C12N]
9187729 Alphavirus and alphavirus replicon particle formulations and methodsJan 24, 11Nov 17, 15[A61K, C12N]
9079943 TC-83-derived alphavirus vectors, particles and methodsMar 28, 14Jul 14, 15[A61K, C12N, C07K]
8709441 TC-83-derived alphavirus vectors, particles and methodsJul 06, 10Apr 29, 14[A61K, C12N]
8680258 Use of microRNAs to control virus helper nucleic acidsNov 25, 09Mar 25, 14[C07H]
8617533 Multi-antigenic alphavirus replicon particles and methodsMay 06, 08Dec 31, 13[A61K, A01N, C12N]
8263092 Alphavirus replicon particles as immunological adjuvantsSep 12, 07Sep 11, 12[A61K]
7850977 Promoterless cassettes for expression of alphavirus structural proteinsJun 20, 08Dec 14, 10[A61K, C12N]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
7910716 Nucleic acids encoding modified South African HIV-1 subtype C gag proteinsExpiredJan 21, 09Mar 22, 11[C07H, A61K]
2009/0022,760 Alphavirus Replicon Particles Matched to Protein Antigens as Immunological AdjuvantsAbandonedSep 12, 07Jan 22, 09[A61K, A61P]
2007/0172,930 process for the selection of HIV-1 subtype C isolates, selected HIV-1 subtype isolates, their genes and modifications and derivatives thereofAbandonedMar 15, 07Jul 26, 07[A61K, C12Q, C12P]
2006/0099,587 Alphavirus vectors having attentuated virion structural proteinsAbandonedJun 20, 03May 11, 06[C12Q, C12N]
2005/0266,550 TC-83-derived alphavirus vectors, particles and methodsAbandonedMay 18, 05Dec 01, 05[A61K, C12P, C12N]
2004/0208,848 Multi-antigenic alphavirus replicon particles and methodsAbandonedDec 12, 03Oct 21, 04[A61K, C12N]
2004/0116,660 Process for the selection of hiv-1 subtype c Isolates, selected hiv-1 subtype c isolates, their genes and modifications and derivatives thereofAbandonedSep 12, 03Jun 17, 04[C07H, C12Q, C12N, C07K]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.